PhRMA: David Ricks, board chairman
The Pharmaceutical Research and Manufacturers of American (PhRMA) has named Eli Lilly chair and CEO David Ricks as the organization’s new board chair. He succeeds Giovanni Caforio, chair and CEO of Bristol Myers Squibb, in the role.
"Our companies and their scientists have moved with speed and collaborated like never before to develop and now launch therapeutics and vaccines which will allow more people to survive and avoid COVID-19 infections," said Ricks. "We are committed to harnessing that same scientific capability to conquer the scourges of cancer, diabetes, Alzheimer's and other chronic diseases, while bringing the same collaborative spirit to the policy table in 2021 to solve the inequity and unfairness due to expanding out-of-pocket costs for American families and seniors in our health care system."
